Page 73 - 78_02

DANIEL
ARCOS

47. Xia,
W.,
&
Chang,
J.
(2006).
Well-­-ordered
mesoporous
bioactive
glasses
(MBG):
A
promising

bioactive
drug
delivery
system.
J.
Control
Rel.,
110,
522-­-530.

48. Xia,
W.,
&
Chang,
J.
(2008).
Preparation,
in
vitro
bioactivity
and
drug
release
property
of
well-­-
ordered
mesoporous
58S
bioactive
glass.
J.
Non-­-Cryst.
Solids,
354,
1338-­-1341.

49. Zhao,
L.
Z.,
Yan,
X.
X.,
Zhou,
X.
F.,
Zhou,
L.,
Wang,
H.
N.,
Tang,
J.
W.,
&
Yu,
C.
Z.
(2008).
Mesoporous
bioactive
glasses
for
controlled
drug
release.
Microporous
Mesoporous
Mater,

109,
210-­-215.

50. Zhao,
Y.
F.,
Loo,
S.
C.
J.,
Chen,
Y.
Z.,
Boey,
F.
Y.
C.,
&
Ma,
J.
(2008). In
situ
SAXRD
study
of
sol–gel

induced
well-­-ordered
mesoporous
bioglasses
for
drug
delivery.

J.
Biomed.
Mater.
Res.,
85A,

1032-­-1042.

51. Sun,
J.,
Li,
Y.
S.,
Li,
L.,
Zhao,
W.
R.,
Li,
L.,
Gao,
J.
H.,
Ruan,
M.
L.,
&
Shi,
J.
L.
(2008).

Functionalization
and
bioactivity
in
vitro
of
mesoporous
bioactive
glasses.

J.
Non-­-Cryst.

Solids,
354,
3799-­-3805.

52. López-­-Noriega,
A.,
Arcos,
D.,
&
Vallet-­-Regí,
M.
(2010).
Functionalizing
Mesoporous
Bioglasses

for
Long-­-Term
Anti-­-Osteoporotic
Drug
Delivery.
Chem.
Eur.
J.,
16,
10879-­-10886.

53. Ostomel,
T.
A.,
Shi,
Q.
H.,
Tsung,
C.
K.,
Liang,
H.
J.,
&
Stucky,
G.
D.
(2006).
Spherical
Bioactive

Glass
with
Enhanced
Rates
of
Hydroxyapatite
Deposition
and
Hemostatic
Activity.

Small,
2,

1261-­-1265.

54. Ostomel,
T.
A.,
Shi,
Q.,
&
Stucky,
G.D.
(2006).
Oxide
hemostatic
activity.
J.
Am.
Chem.
Soc.,
128,

8384-­-8385.

55. Arcos,
D.,
López-­-Noriega,
A.,
Ruiz-­-Hernández,
E.,
Terasaki,
O.,
&
Vallet-­-Regí,
M.
(2009).

Ordered
mesoporous
microspheres
for
bone
grafting
and
drug
delivery.
Chem.
Mater.,
21,

1000-­-1009.

56. Yun,
H-­-S.,
Kim,
S-­-H.,
Lee,
S.
Y.,
&
Song,
I-­-H.
(2010).
Synthesis
of
high
surface
area
mesoporous

bioactive
glass
nanospheres.
Mater
Lett.,
64,
1850-­-1853.

57. Zhao,
S.,
Li,
Y.
B.,
&
Li,
D.
X.
(2010).
Synthesis
and
in
vitro
bioactivity
of
CaO–SiO2–P2O5

mesoporous
microspheres.
Microporous
Mesoporous
Mater.,
135,
67-­-73.

58. Li,
X.,
Zhang,
L.
X.,
Dong,
X.
P.,
Liang,
J.,
&
Shi,
J.
L.
(2007).
Preparation
of
mesoporous
calcium

doped
silica
spheres
with
narrow
size
dispersion
and
their
drug
loading
and
degradation

behavior.
Microporous
Mesoporous
Mater.,
102,
151-­-158.

59. Li,
X.,
Wang,
X.
P.,
Zhang,
L.
X.,
Chen,
H.
R.,
&
Shi,
J.
L.
(2009).
MBG/PLGA
Composite

Microspheres
with
Prolonged
Drug
Release.
J
Biomed
Mater
Res
Appl
Biomater.,
89B,
148-­-154.

60. Hong,
Y.
L.,
Chen,
X.
S.,
Jing,
X.
B.,
Fan,
H.
S.,
Gu,
Z.
W.,
&
Zhang,
X.
D.
(2010).
Fabrication
and

Drug
Delivery
of
Ultrathin
Mesoporous
Bioactive
Glass
Hollow
Fibers.
Adv.
Funct.
Mater.,
20,

1503-­-1510.

61. Lin,
H.-­-M.,
Wang,
W.-­-K.,
Hsiung,
P.-­-A.,
&
Shyu,
S.-­-G.
(2010).
Light-­-sensitive
intelligent
drug

delivery
systems
of
coumarin-­-modified
mesoporous
bioactive
glass.
Acta
Biomaterialia.,
6,

3265-­-3263.

62. Vivero-­-Escoto,
J.
L.,
Slowing,
I.
I.,
Trewyn,
B.
G.,
&
Lin,
V.
S.-­-Y.
(2010).
Mesoporous Silica
Nanoparticles for Intracellular Controlled Drug Delivery. Small,
6,
1952-­-1967.

63. Martín-­-Saavedra,
F.,

Ruíz-­-Hernández,
E.,
Boré,
A.,
Arcos,
D.,
Vallet-­-Regí,
M.,
&

Vilaboa,
N.

(2010).
Magnetic
mesoporous
silica
spheres
for
hyperthermia
therapy.

Acta
Biomaterialia,
6,

4522-­-
4561.

64. Julian-­-López,
B.,

Boissiere,
C.,

Chaneac,
C.,
Grosso,
D.,
Vasseur,
S.,
Miraux,
S.,
Duguet,
E.,
&

Sanchez,
C.
(2007).
Mesoporous
maghemite–organosilica
microspheres:
a
promising
route

towards
multifunctional
platforms
for
smart
diagnosis
and
therapy.
J.
Mater.
Chem.,
17,
1563-­-
1569.

210